AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth Care
Stem CellsStem Cell TransplantationHematopoietic Stem CellsEmbryonic Stem CellsAdult Stem CellsHematopoietic Stem Cell TransplantationPluripotent Stem CellsStem Cell NicheNeural Stem CellsInduced Pluripotent Stem CellsCell DifferentiationMesenchymal Stem Cell TransplantationMultipotent Stem CellsTransplantation, HomologousMesenchymal Stromal CellsStem Cell FactorBone Marrow TransplantationCell LineageStem Cell ResearchPlant StemsFetal Stem CellsHematopoietic Stem Cell MobilizationCell ProliferationCells, CulturedBone Marrow CellsNeoplastic Stem CellsPeripheral Blood Stem Cell TransplantationTransplantation ConditioningMice, Inbred C57BLRegenerationTransplantation, AutologousOctamer Transcription Factor-3Cell SeparationHematopoiesisCell Culture TechniquesAntigens, CD34Flow CytometryRegenerative MedicineTotipotent Stem CellsCord Blood Stem Cell TransplantationGraft vs Leukemia EffectSignal TransductionTransplantation ChimeraEmbryo, MammalianSOXB1 Transcription FactorsMice, SCIDColony-Forming Units AssayHistocompatibilitySpermatogoniaTissue DonorsGraft SurvivalCell- and Tissue-Based TherapyTissue EngineeringGene Expression Regulation, DevelopmentalWhole-Body IrradiationLymphocyte TransfusionProto-Oncogene Proteins c-kitCell LineFetal BloodGraft vs Tumor EffectNestinMice, TransgenicReverse Transcriptase Polymerase Chain ReactionBiological MarkersAcute DiseasePhenotypeTime FactorsCoculture TechniquesBone MarrowGene Expression ProfilingAntigens, CDCell DivisionGerm CellsCell SurvivalHomeodomain ProteinsGranulocyte Colony-Stimulating FactorHair FollicleBrain StemEmbryo ResearchChimeraModels, BiologicalImmunosuppressive AgentsRadiation ChimeraNeuronsCell TransplantationCell DedifferentiationImmunohistochemistryBusulfanTreatment OutcomeGene Expression RegulationT-LymphocytesTranscription FactorsGreen Fluorescent ProteinsCell MovementTeratomaMice, Inbred NODAnemia, AplasticEmbryoid BodiesNuclear ReprogrammingLymphocyte Depletion
HSCTGraftTransplantationMorbidity and mortaRecipientsPost-transplantBoneChemotherapyChronic GVHDIncidenceProphylaxisComplicationsBlood stemTherapiesCentersPatient'sPediatricSquamous cell carcCord blood transplantsImmune cellsReview summarizesOveractive immune responseOccursTreatmentsPatients with acuteProcedureRecipient'sCurativePotentiallyUmbilicalChild's transplantDonor'sCancersIntestinalRelapseSevereUses donorPathogenesisTissueFungalAllogeneic and autologousClinicalDonor T cellsOutcomesOutcomeLeukemiaInfectionLiverSymptoms
HSCT27
  • Researchers at The University of Texas MD Anderson Cancer Center have identified a specific gut bacterium involved in the progression of graft-versus-host disease (GVHD) after antibiotic treatment of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and discovered that nutritional supplementation can prevent antibiotic-induced GVHD in preclinical models, according to a study published today in Cell . (patriotnewsorganization.com)
  • Broad-spectrum antibiotics often given during allo-HSCT have been linked to an increase in developing GVHD-a condition in which donor immune cells attack the recipient tissues-but the underlying reasons for this have remained unclear. (patriotnewsorganization.com)
  • In this study, treating allo-HSCT laboratory models with meropenem-a commonly used broad-spectrum antibiotic-resulted in a thinned colonic mucus layer and intestinal GVHD. (patriotnewsorganization.com)
  • Moreover, there had not previously been a clear understanding of how the sugar composition in the gut is altered by antibiotics, or how it affects GVHD following allo-HSCT. (patriotnewsorganization.com)
  • We are not aware of anyone previously trying a sugar supplementation strategy for suppressing gut inflammation from GVHD, so this offers a compelling, low-risk approach in helping allo-HSCT patients who need to be on broad-spectrum antibiotics in order to treat infections," Jenq said. (patriotnewsorganization.com)
  • HSCT survivor with active hepatitis B or C HSCT survivor on any TKI for either Philadelphia chromosome positive cancers or for GVHD treatments or for any other indication (e.g., imatinib for GIST, sorafenib for FLT3+ AML etc. (mayo.edu)
  • Graft versus host disease (GVHD), a severe immunogenic complication of allogeneic hematopoietic stem cell transplantation (HSCT), represents the most frequent cause of transplant-related mortality (TRM). (hindawi.com)
  • Despite a huge progress in HSCT techniques and posttransplant care, GVHD remains a significant obstacle in successful HSCT outcome. (hindawi.com)
  • Allogeneic hematopoietic stem cell transplantation (HSCT) offers the only curative modality for many hematological disorders. (hindawi.com)
  • Due to advances in transplant approaches and supportive care, the use of HSCT is increasing worldwide. (hindawi.com)
  • Despite such a progress, HSCT is still associated with substantial transplant-related mortality (TRM). (hindawi.com)
  • Inherited genetic variants such as single-nucleotide polymorphisms (SNPs) of candidate genes, encoding various cytokines, chemokines, and inflammatory regulators, have become a subject of interest of genetic studies searching for independent predictors of GVHD development and HSCT outcome [ 4 - 7 ]. (hindawi.com)
  • On one end of the spectrum, invasive aspergillosis (IA) predominantly affects patients with profound defects in immune function, such as haematopoietic stem cell transplant (HSCT) or solid organ transplant recipients, and patients undergoing chemotherapy or taking corticosteroids. (bmj.com)
  • Likewise, many children are now surviving hematopoietic stem-cell transplantation (HSCT) (see related histology slide below) and require structured long-term follow-up care. (medscape.com)
  • This episode paralleled with a massive CD8 T- lymphocyte expansion (CD3-663, CD4 106, CD8-568 cells/microliter) following granulocyte infusions, which peaked at day +10 post HSCT. (ebmt.org)
  • Allogeneic hematopoietic stem cell transplantation (HSCT) remains the only curative therapy for sickle cell disease (SCD). (haematologica.org)
  • Various XSCID gene therapy clinical trials have been conducted over 20 years, both as an alternative to hematopoietic stem cell transplant (HSCT) or following a poor outcome. (stjude.org)
  • Historically, the most effective treatment for XSCID has been bone marrow transplantation, [i.e. hematopoietic stem cell transplantation (HSCT)], where a patient receives healthy blood-forming cells from a matched sibling donor, or a half-matched parental donor. (stjude.org)
  • T-cell immunity may also decrease over time, requiring 26% of patients to undergo a second HSCT. (stjude.org)
  • The most common adverse event following allogeneic hematopoietic stem cell transplantation (HSCT) is graft-versus-host disease (GVHD), which can increase morbidity and mortality in HSCT patients. (oncologynurseadvisor.com)
  • Recent studies are investigating the efficacy of rituximab (Rituxan) for GVHD in pediatric HSCT patients. (oncologynurseadvisor.com)
  • Hematopoietic stem cell transplants ("HSCTs") provide an often-curative option for many patients with hematological and oncological conditions, with multiple myeloma, Non-Hodgkin lymphoma, and acute myelogenous leukemia being the most common diseases requiring an HSCT treatment. (wivb.com)
  • Infections include hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD) or those with haematologic malignancies with prolonged neutropenia (low white blood cell counts) from chemotherapy. (pharmaceutical-technology.com)
  • The trail was also carried out on patients who had undergone HSCT and were receiving immunosuppressive therapy for prevention or treatment of GVHD. (pharmaceutical-technology.com)
  • The Hematopoietic stem cell transplantation (HSCT) is used in children as a definitive treatment for various oncological, immune deficiencies, hemoglobinopathy, and malignancies diseases that involve the hematological system, congenital metabolism disorders, among others. (bvsalud.org)
  • The allogeneic HSCT was the most frequently performed (57.14%) and the most used source of Hematopoietic progenitor cells (HPC) was the peripheral blood (54.29%) and 5.71% of these patients developed the Graft versus Host Disease (GVHD), of which one was affected by acute GVHD and another by chronic GVHD. (bvsalud.org)
  • Hematopoietic stem cell transplantation not responded to other therapeutic modalities, with (HSCT) is used in children as a definitive treatment an increase in survival after transplantation, for different oncological, immune deficiencies, contributing to its use (YEILIPEK, 2014). (bvsalud.org)
Graft39
  • An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. (nature.com)
  • Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation. (nature.com)
  • Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD). (nature.com)
  • Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic stem cell transplantation. (nih.gov)
  • Graft-versus-host disease (GvHD) is a syndrome, characterized by inflammation in different organs. (wikipedia.org)
  • White blood cells of the donor's immune system which remain within the donated tissue (the graft) recognize the recipient (the host) as foreign (non-self). (wikipedia.org)
  • GvHD can also occur after a blood transfusion, known as Transfusion-associated graft-versus-host disease or TA-GvHD if the blood products used have not been gamma irradiated or treated with an approved leukocyte reduction system. (wikipedia.org)
  • The chronic form of graft-versus-host disease (cGvHD) normally begins 90 to 600 days post-transplant. (wikipedia.org)
  • Graft versus host disease (GVHD) represents the most frequent cause of TRM. (hindawi.com)
  • Shortly before graft infusion, GVHD prophylaxis (immunosuppression) is started. (hindawi.com)
  • When abatacept is given intravenously to prevent graft versus host disease, it is usually injected slowly over 60 minutes on the day before hematopoietic stem-cell transplant and then on days 5, 14, and 28 after the transplant. (medlineplus.gov)
  • It�s known that using umbilical cord blood to perform transfusions lowers the risk of graft vs. host disease, but what exactly is GVHD? (pregnancy-info.net)
  • If this transplanted immune system known as the graft attacks the body of the host recipient, then the patient has GVHD. (pregnancy-info.net)
  • In addition to complications seen from exposure to chemotherapy and radiation, patients undergoing allogeneic transplantation can experience unique late effects secondary to graft versus host disease (GVHD) and autoimmunity. (medscape.com)
  • We present a case of HLH secondary to graft vs host disease (GVHD) in a patient who underwent simultaneous liver-kidney transplant (SLKT). (asn-online.org)
  • Keywords: Hemophagocytic lymphohistiocytosis (HLH), graft versus host disease (GVHD). (asn-online.org)
  • They also report for the first time that having a lower diversity of microbiota before transplant resulted in a higher incidence of graft-versus-host disease. (mskcc.org)
  • One of the most serious complications of blood stem cell or bone marrow transplants (BMTs) , which are used to treat many types of blood cancer, is graft-versus-host disease (GVHD). (mskcc.org)
  • Patients who relapse after stem cell transplantation are typically treated with what is called donor lymphocyte infusion (DLI), but the response rates are typically low and often complicated by graft versus host disease (GVHD) causing significant morbidity and mortality. (lls.org)
  • Graft-versus-host disease (GVHD) is the leading cause of complications after an allogeneic stem cell transplant. (uchicagomedicine.org)
  • T-replete mismatched cord blood transplant (TRCB) offers an augmented graft versus leukemia (GVL) effect mediated by alloreactive donor T cells and thereby presents a potential for long term remission and cure in high risk and relapsed refractory AML in children. (ebmt.org)
  • In addition, 28% experience acute graft-vs-host disease (GvHD), and 15% experience chronic GVHD. (stjude.org)
  • A team of hematology marrow transplant department of the Saint-Louis Hospital AP-HP, the Paris University and INSERM (U976 unit) in collaboration with the Pasteur Institute, led the work on graft against host disease (GVHD) using liquid chromatography coupled with mass spectrometry to study the metabolome of allogeneic patients at Saint-Louis hospital AP-HP. (pasteur.fr)
  • Graft against the host (GVHD) is a major complication that may occur after a allograft, and is characterized by tissue damage induced by donor immune cells which react against those of the recipient. (pasteur.fr)
  • These results published in the journal Nature Communications highlight the major changes in the human metabolome after allograft, associated with alterations of the patient's metabolism or its microbiota, which may represent potential therapeutic targets new for the prevention or treating the graft against the host (GVHD). (pasteur.fr)
  • Developed for decision-makers, this Graft vs. Host Disease - Epidemiology Forecast - 2032 report provides a detailed panorama on the incidence and prevalence of this severe complication of allogeneic stem cell transplantation in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. (researchandmarkets.com)
  • Graft-versus-host disease is a potentially serious complication of allogeneic stem cell transplantation. (researchandmarkets.com)
  • Total allogenic transplant cases of graft-versus-host disease in the 7MM range from ~24,440 in 2022 to ~29,600 in 2032. (researchandmarkets.com)
  • As an allogeneic transplant recipient, the patient might experience either form of Graft vs. Host Disease, either form, or neither. (researchandmarkets.com)
  • The donor immune cells can kill the leftover cancer cells and will exert a "graft-versus-cancer" effect, keeping the cancer cells in check. (parkwaycancercentre.com)
  • Finding a donor with suitable stem cells is critical to avoid graft rejection or graft-versus-host syndrome. (parkwaycancercentre.com)
  • Our renowned specialists offer extracorporeal photopheresis (ECP) for children who have developed graft-versus-host disease (GVHD) after receiving a bone marrow transplant. (ucsfbenioffchildrens.org)
  • This enables broader strategic optionality, including potentially launching Graft versus Host Disease ("GvHD") as a first indication in Europe and Japan. (wivb.com)
  • Despite advances in post-transplant care, the morbidity and mortality of complications such as graft versus host disease (GVHD) and infections remain significant limitations, and hinder the application of this life-saving procedure. (damonrunyon.org)
  • The blood products should, if possible, undergo leukocyte reduction to prevent alloimmunization and CMV transmission and should be irradiated to prevent transfusion-associated graft versus host disease (GVHD) in HCT candidates. (medscape.com)
  • Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients. (cdc.gov)
  • Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation. (cdc.gov)
  • Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation. (cdc.gov)
  • Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation. (cdc.gov)
Transplantation45
Morbidity and morta2
  • The acute or fulminant form of the disease (aGvHD) is normally observed within the first 10 to 100 days post-transplant, and is a major challenge to transplants owing to associated morbidity and mortality. (wikipedia.org)
  • Several studies are analyzing the effectiveness of rituximab in improving morbidity and mortality in pediatric transplant patients. (oncologynurseadvisor.com)
Recipients9
  • Marr KA , Carter RA , Crippa F , Wald A , Corey L . Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. (cdc.gov)
  • The report also includes clinical guidance for adults who have received 7-valent PCV (PCV7) only and adults who are hematopoietic stem cell transplant recipients. (cdc.gov)
  • About one-third to one-half of allogeneic transplant recipients will develop acute GvHD. (wikipedia.org)
  • GVHD occurs in about 30-50% and 70% of recipients allografted from matched related and matched unrelated donors, respectively [ 1 ]. (hindawi.com)
  • Invasive aspergillosis develops in severely immunocompromised patients, including those with neutropenia, and increasingly in the non-neutropenic host, including lung transplant recipients, the critically ill patients and patients on steroids. (bmj.com)
  • Recently rediscovered is Aspergillus bronchitis in those with cystic fibrosis (CF), bronchiectasis especially, as well as lung transplant recipients and those ventilated in intensive therapy units. (bmj.com)
  • A study done in 2000 looking at recipients of transplants donated from siblings for cord blood and bone marrow found that cord blood transplants recipients were 59% less likely to develop GVHD. (pregnancy-info.net)
  • high-risk patients included male subjects, recipients of stem cells from female donors, patients younger than 10 years, those with nonidentical donors, and those who received radiation therapy in the transplant preparative regimen. (medscape.com)
  • University of Michigan Comprehensive Cancer Center professor of internal medicine Daniel Couriel said prophylaxis against invasive Aspergillus and Candida infections play a major role in the management of severely immunocompromised patients with haematologic malignancies or hematopoietic stem cell transplant recipients at high-risk for these life-threatening fungal infections. (pharmaceutical-technology.com)
Post-transplant2
  • He was re-admitted 4 weeks post-transplant with altered mental status, diarrhea, fever, rash and signs of sepsis. (asn-online.org)
  • In such an intractable, chemo refractory, early post-transplant relapsed disease, where palliative treatment was seemingly the only available option, he was offered an experimental approach with GRANS under which, he was given a T replete, 6/8 mismatched unrelated cord blood stem cell transplant with the administration of third-party pooled granulocytes around the D0. (ebmt.org)
Bone28
  • generic patient-reported measures (n = 7), cancer-specific measures (n = 4), bone marrow transplant-specific measures (n = 2), cGVHD-specific measures (n = 4), and dimension-specific measures (n = 10). (nih.gov)
  • Our team performed one of the very first successful bone marrow transplants more than 50 years ago. (uclahealth.org)
  • For the Pediatric Blood and Bone Marrow Transplant & Cellular Therapies Program, please call 310-825-6708 . (uclahealth.org)
  • The pediatric bone marrow transplant team at UCLA Health provides compassionate care to help give your child the best possible recovery from bone marrow transplant (BMT). (uclahealth.org)
  • Find out more about preparing for bone marrow transplant . (uclahealth.org)
  • The goal of BMT is for the donated cells to enter your child's bone marrow and start making new blood cells. (uclahealth.org)
  • Rest assured that our skilled care team will work to minimize risks and optimize your child's bone marrow transplant recovery. (uclahealth.org)
  • GvHD is commonly associated with bone marrow transplants and stem cell transplants. (wikipedia.org)
  • This is where a patient's healthy blood-forming stem cells are collected from the blood or bone marrow before treatment and then given back to the patient after high-dose intensive chemotherapy. (cancer.gov)
  • While both treatments help your bone marrow to develop new blood cells, studies show allogeneic stem cell transplantations work by causing the donor cells to attack unhealthy cells. (clevelandclinic.org)
  • This bone marrow film at 400X magnification demonstrates a complete absence of hemopoietic cells. (medscape.com)
  • For the first time, researchers have found that having a healthy balance of microorganisms in the body before a bone marrow transplant is associated with higher survival rates after the transplant. (mskcc.org)
  • The expanded analysis now includes 8,767 stool samples from 1,362 people who have had allogeneic stem cell or bone marrow transplants at four centers around the world. (mskcc.org)
  • Director of Bone Marrow Transplant and Cell Therapies, Royal Manchester Children's Hospital, United Kingdom. (ebmt.org)
  • It forms in tissue such as bone marrow and causes blood cells to be produced and enter the bloodstream. (cancersupportcommunity.org)
  • If your child has a serious blood disease, cancer, or a life-threatening disorder and needs a stem cell transplant -- also called a bone marrow transplant -- or advanced cell therapy such as CAR T-cell therapy , our experts can offer you hope. (dukehealth.org)
  • Our pediatric stem cell transplant and cellular therapy specialists have performed more than 2,200 stem cell transplants -- also known as bone marrow transplants -- in children and young adults from across the U.S. and from countries around the world. (dukehealth.org)
  • The three sources of stem cells include bone marrow, umbilical cord blood, and peripheral blood. (oncologynurseadvisor.com)
  • the disease is a side effect that is common after an allogeneic bone marrow transplant. (researchandmarkets.com)
  • HSCs mostly stay in the bone marrow and mature into blood cells as they grow. (parkwaycancercentre.com)
  • Chemotherapy or radiotherapy used to treat these cancers will destroy the HSCs in the bone marrow and abolish the body's ability to regenerate blood cells. (parkwaycancercentre.com)
  • The damaged bone marrow will then be replenished with new stem cells to alleviate the side effects of the high-dose therapy. (parkwaycancercentre.com)
  • In allogeneic stem cell (stem cells from a donor) transplant, there is another benefit in addition to replenishing the HSCs in the bone marrow after chemotherapy or radiotherapy. (parkwaycancercentre.com)
  • Stem cells are collected from the bone marrow - the spongy soft tissues in the bones. (parkwaycancercentre.com)
  • Frequently, stem cells are taken from the pelvic bone, filtered, and stored under special conditions for future transplants. (parkwaycancercentre.com)
  • We do stem cell collections for cancer patients anticipating bone marrow transplant, and plasma pheresis for patients with autoimmune disease to remove antibodies that may be causing the disorder. (ucsfbenioffchildrens.org)
  • Since July 2016, Dr He has been appointed as the medical lead in Bone Marrow Transplant at the Olivia Newton-John Centre in Austin Hospital after the successful establishment of Victoria's third adult allogeneic transplant unit. (epworth.org.au)
  • Aplastic anemia due to the progressive failure of the bone marrow, malignant neoplasias such as acute myeloid leukemia, liver tumors and squamous cell carcinoma are some of the possible evolutions of Fanconi Anemia. (bvsalud.org)
Chemotherapy13
  • Most people diagnosed with diffuse large B-cell lymphoma, the most common form of aggressive NHL, will be cured by initial treatment with chemotherapy. (cancer.gov)
  • But for those who aren't, the prospects of a cure have been uncertain at best, even with additional grueling chemotherapy and stem cell transplant. (cancer.gov)
  • Until recently, the only treatment with the possibility of eliminating recurrent or treatment-resistant diffuse large B-cell lymphoma was more high-dose chemotherapy, followed by an autologous stem cell transplant. (cancer.gov)
  • Earlier findings from the ZUMA-7 trial, which began recruiting patients in 2018, led the Food and Drug Administration (FDA) to approve axi-cel in 2022 for adults with diffuse large B-cell lymphoma that wasn't eliminated by their initial treatment or that returned within 12 months of initial chemotherapy. (cancer.gov)
  • ZUMA-7 enrolled people deemed healthy enough to undergo additional high-dose chemotherapy and, potentially, an autologous stem cell transplant. (cancer.gov)
  • While 94% of people in the axi-cel group received their CAR T cells, only 36% of those in the standard-treatment group were able to have a stem cell transplant because in most cases their disease continued to progress despite chemotherapy, Dr. Westin explained at the ASCO meeting. (cancer.gov)
  • The transplanted cells form the recipient�s new immune system after the destruction of the old system by chemotherapy. (pregnancy-info.net)
  • An environment for GVHD is formed when antigen-presenting cells are activated by the patient's disease and the pretreatment destruction of cells caused by chemotherapy and radiotherapy. (oncologynurseadvisor.com)
  • Before undergoing an allogeneic stem cell transplant, the patient will receive high doses of chemotherapy or radiation to destroy the diseased cells and prepare the body for the donor cells. (researchandmarkets.com)
  • Stem cell therapy, or stem cell transplant, is a procedure that aims to restore blood-forming stem cells in patients who have undergone chemotherapy or radiotherapy . (parkwaycancercentre.com)
  • Autologous stem cell (patient's own stem cells) transplant is used to help patients recover from the effects of chemotherapy. (parkwaycancercentre.com)
  • Allogeneic stem cell (stem cells from a donor) transplant is used to help patients recover from the effects of chemotherapy and/or radiotherapy as well as to eradicate the remaining cancer cells in the patient after chemotherapy and/or radiotherapy. (parkwaycancercentre.com)
  • The patient first receives a high dose of chemotherapy and/ or radiotherapy to eliminate the remaining cancer cells in the body. (parkwaycancercentre.com)
Chronic GVHD5
  • A comprehensive systematic review based on the COSMIN guidelines was conducted to identify studies using PROMs (including those for QOL and symptom burden) in acute and chronic GVHD (cGVHD) patients. (nih.gov)
  • Mucosal damage to the vagina can result in severe pain and scarring, and appears in both acute and chronic GvHD. (wikipedia.org)
  • Chronic GVHD starts affecting the recipient after 3 months. (pregnancy-info.net)
  • Causes of death were related to relapse of the underlying cancer, development of a second cancer, chronic GVHD, or transfusion-acquired viral infection. (medscape.com)
  • Easy access for urgent transplants, greater tolerance of HLA mismatch and very less rate of chronic GVHD are other advantages of cord blood. (ebmt.org)
Incidence2
  • In contrast to organ/tissue transplant associated GvHD, the incidence of TA-GvHD is increased with HLA matching (first-degree or close relatives). (wikipedia.org)
  • The incidence of grade 2/3 bacterial or grade 3 fungal infections 100 days following transplant was 39% with omidubicel, vs 60% with standard transplants. (medscape.com)
Prophylaxis1
  • Fludarabine, Treosulphan and Thiotepa conditioning was used, cislosporin and mycophenolate mofetil (MMF) were used for GVHD prophylaxis. (ebmt.org)
Complications2
  • Researchers led by Eiko Hayase, M.D., Ph.D., postdoctoral fellow, and corresponding author Robert Jenq, M.D., associate professor of Genomic Medicine, discovered that certain antibiotics alter the sugar composition of the gut, forcing a normally beneficial species of bacteria to consume mucin in the intestinal lining, which can lead to complications such as GVHD. (patriotnewsorganization.com)
  • This study is investigating a new method for collecting blood stem cells from donors to see if it reduces transplant complications, such as rejection, in patients who have blood diseases. (nih.gov)
Blood stem5
  • Are you considering a blood stem cell transplant? (nih.gov)
  • When transplanting blood stem cells, it�s important to get as close a match as possible to the recipient�s own immune system characteristics or �markers�. (pregnancy-info.net)
  • He had a busulphan based myeloablative cord blood stem cell transplant with a 6/8 mismatched cord blood. (ebmt.org)
  • Peripheral blood stem cells are the preferred source of HSCs because of the relative ease of collection. (parkwaycancercentre.com)
  • The US Food and Drug Administration (FDA) approved omidubicel-onlv (Omisirge) for reducing infections and hastening neutrophil recovery for blood cancer patients aged 12 years and older who are undergoing allogeneic umbilical cord blood stem cell transplants. (medscape.com)
Therapies5
  • Like all currently approved CAR T-cell therapies, axi-cel is truly personalized, in that it uses a patient's own immune cells to create the treatment . (cancer.gov)
  • Cellular reprogramming of ex vivo cells may offer improvements on first-generation adoptive cell therapies, which have experienced limited clinical success. (scienceboard.net)
  • Our inpatient unit is designed specifically for children and young adults receiving stem cell transplants or cellular therapies and for other immunocompromised patients. (dukehealth.org)
  • To date, no standard treatment is established for GVHD and no therapies are FDA approved for this indication in pediatric or adult patients. (oncologynurseadvisor.com)
  • The number of allogeneic transplants in Europe and Japan are double that of the United States and since GvHD therapies have a clear reimbursement path in these markets, we see this as a significant opportunity to help more patients desperately in need," said Mark Lappe , CEO of Inhibrx. (wivb.com)
Centers1
  • It is available for order now and is expected to be delivered to transplant centers within 30 days after the start of manufacturing, the company said. (medscape.com)
Patient's4
  • CAR T-cell therapy is a type of treatment in which a patient's T cells (a type of immune cell) are changed in the laboratory so they will bind to cancer cells and kill them. (cancer.gov)
  • Patient's white cell count did not improve despite maximum dose of G-CSF. (asn-online.org)
  • MSK doctors are already conducting research on fecal transplants that make use of a patient's own stool. (mskcc.org)
  • The results of these studies highlight major changes in the human metabolome after allograft, associated with the patient's metabolism alterations and its microbiota, and could represent new potential therapeutic targets for the prevention or treatment of GVHD. (pasteur.fr)
Pediatric4
  • Duke's pediatric stem cell and cellular therapy program is internationally recognized for its innovative use of stem cells to treat a wide range of potentially fatal diseases. (dukehealth.org)
  • This article discusses the current status of clinical trials of rituximab to treat GVHD in the pediatric population. (oncologynurseadvisor.com)
  • Although not a first-line treatment for GVHD, rituximab may offer an alternative treatment option for GVHD in pediatric patients. (oncologynurseadvisor.com)
  • UCSF's pediatric Apheresis Program provides care for children who have sickle cell anemia, thalassemia and other blood disorders, as well as those who need or have recently had a stem cell transplant. (ucsfbenioffchildrens.org)
Squamous cell carc4
  • Notably, we are presenting the first survival data for neoadjuvant Libtayo therapy in cutaneous squamous cell carcinoma and the first results for Libtayo in combination with ubamatamab, our investigational MUC16xCD3 bispecific antibody, in recurrent ovarian cancer. (biospace.com)
  • Additional presentations at ESMO include subgroup analyses of Libtayo in advanced non-small cell lung cancer (NSCLC), focusing on such populations as squamous cell carcinoma and patients with varying levels of PD-L1 expression. (biospace.com)
  • Cancer that grows beyond this layer into the deeper tissue is called invasive squamous cell carcinoma . (cancerquest.org)
  • Papillary atrophy, macroglossia, melanic pigmentation and squamous cell carcinoma are the most common oral manifestations on the tongue. (bvsalud.org)
Cord blood transplants2
  • This study will assess the safety and effectiveness of certain cord blood transplants. (nih.gov)
  • The FDA approval was based on phase 3 testing that pitted the use of omidubicel in 62 patients against standard unmanipulated cord blood transplants in 63 patients following myeloablative conditioning. (medscape.com)
Immune cells7
  • This is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. (clevelandclinic.org)
  • In this condition, a donor's immune cells attack the vital organs of a transplant recipient. (mskcc.org)
  • In recent years we have witnessed a revolution in developing novel treatments aimed at targeting cancer by immune cells like T cells. (lls.org)
  • Now, more than 2 years after undergoing this new gene therapy, initial patients are producing a greater percentage of immune cells, including T, B and natural killer cells. (stjude.org)
  • In 3 younger patients, similar levels of gene-modified immune cells were also observed at 6 to 9 months following treatment. (stjude.org)
  • Indoles derivatives are ligands of the receptor Aryl Hydrocarbon (AhR), which regulates the activation and differentiation of immune cells and could therefore contribute to limiting the risk of immune reaction to allogeneic origin of GVHD. (pasteur.fr)
  • Dr. Turtle will test the hypotheses that alterations in the bacterial composition of the human gastrointestinal tract regulate the reconstitution of a specialized bacteria-responsive subset of immune cells after HCT, and that impaired regulation of this immune cell subset is associated with an increased risk of infection or GVHD. (damonrunyon.org)
Review summarizes2
  • This review summarizes the current evidence regarding the use of 27 included PROMs in the context of GVHD. (nih.gov)
  • This review summarizes the updated GVHD pathogenesis linking GVHD with biological processes such as DNA damage response (DDR) and cellular senescence (Figure 1 ). (hindawi.com)
Overactive immune response1
  • Systemic medicines that are designed to control the overactive immune response of GVHD. (uchicagomedicine.org)
Occurs5
  • GvHD occurs when the donor's immune system's white blood cells reject the recipient. (wikipedia.org)
  • Acute GVHD occurs most frequently 30-40 days after engraftment. (hindawi.com)
  • Besides the secretion of pro-inflammatory cytokines (TNF-alpha, IL-1beta, and IL-6), the increased expression of receptor repertoire (pattern recognition receptors, PRR) on APCs, mostly macrophages and dendritic cells, occurs as a result of the release of endogenous and exogenous antigens (damage-associated molecular patterns, DAMPs, and pathogen-associated molecular patterns, PAMPs). (hindawi.com)
  • GVHD is a potentially fatal complication that occurs following a transplant of stem cells from either a related or allogeneic donor. (pregnancy-info.net)
  • Microsatellite instability (or MSI) is defined by the National Cancer Institute as a change that occurs in the DNA of certain cells, such as tumor cells, in which the number of repeats of microsatellites (short, repeated sequences of DNA) is different from the number of repeats that was in the DNA when it was inherited. (merck.com)
Treatments1
  • These patients face a unique challenge due to the complexity of GVHD and the toxicity of treatments received. (nih.gov)
Patients with acute3
  • Only 5 included PROMs were used in patients with acute GVHD. (nih.gov)
  • Conversely, patients with acute GVHD had high rates of complex lipids, such as fatty acids to medium or long-chain, polyunsaturated fatty acids and bile acids. (pasteur.fr)
  • Indoles derivatives, a group of metabolites produced by the microbial metabolism of tryptophan, were also among the more impaired in patients with acute GVHD. (pasteur.fr)
Procedure1
  • The upper part of this scheme shows transplant procedure in time with important time points of transplant management. (hindawi.com)
Recipient's3
  • The white blood cells present within the transplanted tissue then attack the recipient's body's cells, which leads to GvHD. (wikipedia.org)
  • In the past few years, researchers from Memorial Sloan Kettering and other institutions have found that a transplant recipient's microbiota plays an important role in their survival after a BMT. (mskcc.org)
  • GVHD happens when donor cells attack the recipient's tissues causing problems in many parts of the body, including the eyes, gastrointestinal tract, lungs, mouth, skin and more. (uchicagomedicine.org)
Curative2
  • Hematopoietic stem cell transplant remains a curative option, however a significant number of patients relapse after the transplant and there are currently no effective and safe treatment options available for these patients. (lls.org)
  • Allogeneic hematopoietic stem cell (HSC) is a curative treatment used for many hematologic malignancies and congenital or acquired anomalies of hematopoiesis. (pasteur.fr)
Potentially1
  • When CD20 antagonists decrease the amount of circulating B cells, the body may not produce as many cytotoxic T cells that can potentially induce GVHD. (oncologynurseadvisor.com)
Umbilical4
Child's transplant2
  • The day of your child's transplant is "day zero. (uclahealth.org)
  • We provide compassionate, individualized care for every child and guide you and your family through your child's transplant journey. (dukehealth.org)
Donor's2
  • The histocompatibility differences between the donor and the recipient, the presence of donor's immunocompetent cells, and the inability of the recipient to reject these cells were defined as the basic pathogenic prerequisites for GVHD development by Billingham in 1966 [ 10 ]. (hindawi.com)
  • The current understanding of aGVHD pathogenesis can be summarized as (1) initial tissue damage induced by the conditioning regimen followed by the denudation of auto- and alloantigens accompanied by massive inflammatory cytokine secretion ("cytokine storm") activating APCs, (2) auto- and alloantigen presentation mediated by APCs together with the costimulatory signaling prime donor's cytotoxic T lymphocytes and their proliferation, and (3) the migration of activated cellular effectors toward GVHD target tissues. (hindawi.com)
Cancers5
  • Researchers have used a form of CRISPR, called base editing, to engineer T cells and hematopoietic stem cells as part of a potential "universal" CAR T-cell therapy for blood cancers. (cancer.gov)
  • Most head and neck cancers are squamous cell carcinomas that develop in the upper throat as a result of exposure to risk factors. (cancerquest.org)
  • More recently, genetically modified T cells called CAR T cells have proven quite effective against various lymphoid cancers. (lls.org)
  • Stem cell transplant is often a part of the treatment plan for blood cancers. (parkwaycancercentre.com)
  • The FDA's "approval is an important advance in cell therapy treatment in patients with blood cancers. (medscape.com)
Intestinal2
  • Acute GvHD of the GI tract can result in severe intestinal inflammation, sloughing of the mucosal membrane, severe diarrhea, abdominal pain, nausea, and vomiting. (wikipedia.org)
  • The findings confirmed that a having a greater diversity of species in the intestinal microbiota is associated with a lower risk of death after having a transplant. (mskcc.org)
Relapse2
  • Conforming with an aggressive disease, there was a frank disease relapse immediately after the transplant, which failed to respond to bridging treatment including venetoclax. (ebmt.org)
  • 1) In a multi-centric retrospective analysis of children who received stem cell transplant for high-risk AML, TRCB cohort had significantly improved event free survival and time to relapse and overall survival compared to the children who received stem cell transplant from other sources. (ebmt.org)
Severe6
  • We hypothesized that clinical risk factors could be identified within 2 weeks of onset of severe (stage 3 or 4) acute gut GVHD for identifying a patient population with a very poor outcome. (nature.com)
  • This information should be considered in designing future studies of severe gut GVHD and in counseling patients about prognosis. (nature.com)
  • If the GvHD is severe and requires intense immunosuppression involving steroids and additional agents to get under control, the patient may develop severe infections as a result of the immunosuppression and may die of infection. (wikipedia.org)
  • Posoleucel is the first T-cell therapy to target BK virus, which can cause severe, painful bladder infections requiring immediate treatment. (scienceboard.net)
  • His cell counts, kidney function and liver tests were within normal range at admission but he later developed severe pancytopenia and a very high ferritin (15,910 ng/mL). (asn-online.org)
  • GVHD symptoms vary by person, and can be mild, moderate or severe. (uchicagomedicine.org)
Uses donor1
  • GVHD is a common problem that may occur after an allogeneic stem cell transplant, which is a stem cell transplant that uses donor cells. (uchicagomedicine.org)
Pathogenesis5
  • This review presents a complex summary of GVHD pathogenesis with focus on references considering basic biological processes such as DNA damage response and cellular senescence. (hindawi.com)
  • With the growing understanding of GVHD pathogenesis, there is increasing attraction to non-HLA genotype as a tool to GVHD prediction in the last ten years [ 3 ]. (hindawi.com)
  • GVHD pathogenesis corresponding to transplant time axis is shown in 3 phase-based concepts in the middle of the scheme. (hindawi.com)
  • Biological processes underlying GVHD pathogenesis are shown at the bottom of the scheme. (hindawi.com)
  • CD20 antagonists deregulate B cells, which are believed to contribute to the pathogenesis of GVHD. (oncologynurseadvisor.com)
Tissue1
Fungal6
  • Because stem cell transplants destroy and rebuild your immune system, they increase your risk for fungal infections. (cdc.gov)
  • A transplant using stem cells from a donor increases your risk for fungal infection more than a transplant that uses stem cells from your own body. (cdc.gov)
  • Fungal infections can happen any time after your transplant. (cdc.gov)
  • Fungal infections can happen days, weeks, or months after the stem cell transplant. (cdc.gov)
  • Some types of fungal infections are more common than others in stem cell transplant patients. (cdc.gov)
  • Aspergillosis is the most common type of fungal infection in stem cell transplant patients, followed by Candida infection and mucormycosis, but other types of fungal infections are also possible. (cdc.gov)
Allogeneic and autologous1
  • What's the difference between allogeneic and autologous stem cell transplantations? (clevelandclinic.org)
Clinical8
  • This study aims to monitor the long-term health of patients who have received a donor stem cell transplant from the NIH Clinical Center. (nih.gov)
  • That's according to updated results from a large randomized phase 3 clinical trial of the CAR T-cell therapy axicabtagene ciloleucel (Yescarta) . (cancer.gov)
  • Now, new data from the ZUMA-7 clinical trial strongly suggests that axi-cel, as this CAR T-cell therapy is often called, can offer real hope for this latter group of patients. (cancer.gov)
  • This landscape began to change in 2021, when the results of two large clinical trials showed that CAR T cells could improve the time that people with treatment-resistant or recurrent large B-cell lymphoma lived without their cancer getting worse. (cancer.gov)
  • Tarlatamab, a new type of targeted immunotherapy, shrank small cell lung cancer (SCLC) tumors in more than 30% of participants in an early-stage clinical trial. (cancer.gov)
  • Use of memory-like NK cells was safe and associated with very promising results in our small clinical trial in patients with advanced AML. (lls.org)
  • The vector was made on our campus by our GMP facility that produces clinical grade biological products, which also re-engineers the patients' cells to carry the healthy new gene. (stjude.org)
  • Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant. (cdc.gov)
Donor T cells4
  • Posoleucel, an allogeneic therapy comprising donor T cells, targets six of the most common viruses in patients following allo-SCT: adenovirus, BK virus, cytomegalovirus (CMV), Epstein-Barr virus, human herpes virus 6, and JC virus. (scienceboard.net)
  • Since posoleucel utilizes healthy donor T cells rather than T cells from the patient or transplant donor, it avoids an otherwise lengthy development process, making it more readily available. (scienceboard.net)
  • Donor T-cells proliferate and inflammatory mediators are recruited. (oncologynurseadvisor.com)
  • Treatment focuses on blocking the expansion of donor T cells, as GVHD develops from the expansion of these cells. (oncologynurseadvisor.com)
Outcomes1
  • Abbey Jenkins, president and CEO of Gamida, called the approval "a major advancement in the treatment of patients with hematologic malignancies that we believe may increase access to stem cell transplant and help improve patient outcomes. (medscape.com)
Outcome1
  • Despite the availability of patient-reported outcome measures (PROMs) to assess QOL, there is currently no consensus regarding the optimal PROMs that should be used to evaluate the impact of GVHD. (nih.gov)
Leukemia3
  • Early T-cell expansion post T-replete mismatched cord transplant with granulocytes is associated with induction of remission and sustenance in relapsed-refractory high risk acute myeloid leukemia. (ebmt.org)
  • Leukemia is cancer of the blood cells. (cancersupportcommunity.org)
  • The versatile drug is now also approved for the treatment of B-cell Hodgkin lymphoma, non-Hodgkin lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis in the adult population. (oncologynurseadvisor.com)
Infection4
  • T-cells act on foreign materials that enter the body as a defense against disease and infection. (pregnancy-info.net)
  • It usually starts in white blood cells, which are strong infection fighters. (cancersupportcommunity.org)
  • Infection and GVHD are influenced by the immune system, which in turn is regulated by the bacterial contents of the human gastrointestinal tract. (damonrunyon.org)
  • Cite this: FDA OKs Stem Cell Therapy to Reduce Infection Risk in Blood Cancer Patients - Medscape - Apr 18, 2023. (medscape.com)
Liver4
  • Liver GvHD is measured by the bilirubin level in acute patients. (wikipedia.org)
  • Acute GvHD is staged as follows: overall grade (skin-liver-gut) with each organ staged individually from a low of 1 to a high of 4. (wikipedia.org)
  • If GVHD has affected the liver, the recipient will notice a yellowing of skin. (pregnancy-info.net)
  • HLH has also been reported after kidney, liver and hematopoietic stem cell transplants. (asn-online.org)
Symptoms3